Cargando…

Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy

Retinopathy is a threat to the eyesight, and glaucoma and diabetes are the main causes for the damage of retinal cells. Recent insights pointed out a common pathogenetic pathway for both disorders, based on chronic inflammation. Palmitoylethanolamide (PEA) is an endogenous cell protective lipid. Sin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keppel Hesselink, Jan M., Costagliola, Ciro, Fakhry, Josiane, Kopsky, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667059/ https://www.ncbi.nlm.nih.gov/pubmed/26664738 http://dx.doi.org/10.1155/2015/430596

Ejemplares similares

The retinoprotective role of phenytoin
por: Bartollino, Silvia, et al.
Publicado: (2018)

Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015)

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013)

Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical
por: Hesselink, Jan M Keppel
Publicado: (2013)

Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold
por: Keppel Hesselink, J. M., et al.
Publicado: (2013)

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
por: Hesselink, Jan M Keppel, et al.
Publicado: (2012)

Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection
por: Hesselink, J M Keppel
Publicado: (2013)

Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats
por: Szabo, Edina, et al.
Publicado: (2021)

Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?
por: Hesselink, Jan M Keppel, et al.
Publicado: (2016)

Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report
por: Kopsky, David J., et al.
Publicado: (2011)

Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series
por: Kopsky, David J., et al.
Publicado: (2018)

Single-Blind Placebo-Controlled Response Test with Phenytoin 10% Cream in Neuropathic Pain Patients
por: Kopsky, David J., et al.
Publicado: (2018)

Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017)

Delivery Systems of Retinoprotective Proteins in the Retina
por: Rebustini, Ivan T., et al.
Publicado: (2021)

Retinoprotective compounds, current efficacy, and future prospective
por: Marino, Rachele, et al.
Publicado: (2023)

Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
por: Kopsky, David J., et al.
Publicado: (2012)

Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
por: Kopsky, David J., et al.
Publicado: (2015)

Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics
por: Keppel Hesselink, Jan M, et al.
Publicado: (2016)

Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
por: Keppel Hesselink, Jan M, et al.
Publicado: (2019)

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design
por: Keppel Hesselink, Jan M, et al.
Publicado: (2017)

Analysis of Lipid Peroxidation by UPLC-MS/MS and Retinoprotective Effects of the Natural Polyphenol Pterostilbene
por: Torres-Cuevas, Isabel, et al.
Publicado: (2021)

Cell-based assays to identify novel retinoprotective agents
por: Bullock, Jeanee, et al.
Publicado: (2020)

New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells
por: Keppel Hesselink, J M, et al.
Publicado: (2016)

Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review
por: Kopsky, DJ, et al.
Publicado: (2019)

Retinoprotective Effect of 2-Ethyl-3-hydroxy-6-methylpyridine Nicotinate
por: Peresypkina, Anna, et al.
Publicado: (2020)

No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action
por: Kopsky, David J, et al.
Publicado: (2022)

Palmitoylethanolamide: A Natural Compound for Health Management
por: Clayton, Paul, et al.
Publicado: (2021)

Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa
por: Gopalakrishnan, Sandeep, et al.
Publicado: (2020)

The natural retinoprotectant chrysophanol attenuated photoreceptor cell apoptosis in an N-methyl-N-nitrosourea-induced mouse model of retinal degenaration
por: Lin, Fan-Li, et al.
Publicado: (2017)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Usefulness of a Double-Blind Placebo-Controlled Response Test to Demonstrate Rapid Onset Analgesia with Phenytoin 10% Cream in Polyneuropathy
por: Kopsky, David J, et al.
Publicado: (2020)

Low-Tension Glaucoma: An Oxymoron in Ophthalmology
por: Costagliola, Ciro, et al.
Publicado: (2019)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle?
por: Passaro, Maria Laura, et al.
Publicado: (2023)

Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone
por: Wachal, Zita, et al.
Publicado: (2020)

Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis
por: Amorim, Madania, et al.
Publicado: (2022)

Retinoprotective Effect of Wild Olive (Acebuche) Oil-Enriched Diet against Ocular Oxidative Stress Induced by Arterial Hypertension
por: Santana-Garrido, Álvaro, et al.
Publicado: (2020)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents
por: Santonocito, Simona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vsadjt06tck64nahus9i632l4a